Circulating Tumor Cells As a Window into Lethality in Prostate Cancer

By
Emily Salmini
-
0
72
Understanding the clinical utility of circulating tumour cells (CTCs) and future innovations is crucial to incorporating CTCs into the clinical management of prostate cancer.
[Nature Reviews Urology]
Abstract